Diffusion Tensor Imaging of Patients with HIV and Normal-appearing White Matter on MR Images of the Brain

References

1. ↵
   Simpson DM, Berger JR. Neurological manifestations of HIV infection. Med Clin North Am 1996;80:1363-1394

   PubMedWeb of Science
2. Heaton RK, Grant I, Butters N, et al. The HNRC 500: neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995;3:231-251
3. ↵
   van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG. The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc 1999;5:534-539

   CrossRefPubMedWeb of Science
4. Bencherif B, Rottenberg DA. Neuroimaging and AIDS dementia complex. AIDS 1998;12:233-244

   PubMed
5. ↵
   Filippi CG, Sze G, Farber SJ, Shamanesh M, Selwyn P. Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after initiation of protease inhibitor therapy. Radiology 1998;206:491-499

   PubMedWeb of Science
6. ↵
   Chang L, Ernst T, Leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999;53:782-789

   Abstract/FREE Full Text
7. ↵
   Uluǧ AM, van Zijl PCM. Orientation-independent diffusion imaging without tensor diagonalization: anisotropy definitions based on physical attributes of the diffusion ellipsoid. J Magn Reson Imaging 1999;9:804-813

   CrossRefPubMedWeb of Science
8. ↵
   Uluǧ AM, Moore DF, Bojko AS, Zimmerman RD. Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. AJNR Am J Neuroradiol 1999;20:1044-1048

   Abstract/FREE Full Text
9. ↵
   Shimony JS, McKinstry RC, Akbudak E, et al. Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology 1999;212:770-784

   PubMedWeb of Science
10. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, DiChiro G. Diffusion MR imaging of the human brain. Radiology 1996;201:637-648

    PubMedWeb of Science
11. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36:893-906

    CrossRefPubMedWeb of Science
12. Armitage PA, Bastin ME. Selecting an appropriate anisotropy index for displaying diffusion tensor imaging data with improved contrast and sensitivity. Magn Reson Med 2000;44:117-121

    CrossRefPubMedWeb of Science
13. Papadakis NG, Xing D, Houston GC, et al. A study of rotationally invariant and symmetric indices of diffusion anisotropy. Magn Reson Med 1999;17:881-892
14. van Gorp WG, Mandelkern MA, Gee M, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with dementia and without dementia. J Neuropsychiatry Clin Neurosci 1992;4:280-287

    PubMedWeb of Science
15. ↵
    Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991;22:700-710

    CrossRefPubMedWeb of Science
16. ↵
    Brew BJ, Pemberton L, Cunningham P, Law M. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175:963-966

    Abstract/FREE Full Text
17. ↵
    DiStefano M, Monno L, Fiore JR, et al. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype. AIDS 1998;12:737-743

    CrossRefPubMedWeb of Science
18. Ellis RJ, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997;42:679-688

    CrossRefPubMedWeb of Science
19. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997;42:689-698

    CrossRefPubMedWeb of Science
20. ↵
    Price RW, Strapans S. Measuring the viral load in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection. Ann Neurol 1997;42:675-678

    CrossRefPubMedWeb of Science
21. ↵
    Portegies P. HIV-1, the brain, and combination therapy (letter). Lancet 1995;346:1244-1245

    CrossRefPubMedWeb of Science
22. ↵
    Gisslen M, Hagberg L, Svennerholm B, Norkrans G. HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. AIDS 1997;11:1194

    PubMedWeb of Science
23. Gisslen M, Norkrans G, Svennerholm B, Hagberg L. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine, and indinavir. AIDS 1998;12:114-116

    PubMedWeb of Science
24. ↵
    Ferrando SJ, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment (HAART) in HIV infection: benefits for neuropsychological function. AIDS 1998;12:F65-F70

    CrossRefPubMedWeb of Science
25. ↵
    Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B. Central nervous system as a sanctuary site for HIV-1 infection despite treatment with zidovudine, lamivudine, and indinavir (letter). AIDS 1997;11:1302-1303

    CrossRefPubMedWeb of Science
26. ↵
    Stahle L, Martin C, Svensson JO, Sonnerberg A. Indinavir in the cerebrospinal fluid of HIV-1 infected patients. Lancet 1997;350:1823
27. ↵
    Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990;11:423-429

    Abstract/FREE Full Text
28. Uluǧ AM, Beauchamp N, Bryan RN, van Zijl PCM. Absolute quantitation of diffusion constants in human stroke. Stroke 1997;28:483-490

    Abstract/FREE Full Text